Adriane D.M. Vorselaars

1.8k total citations
35 papers, 1.0k citations indexed

About

Adriane D.M. Vorselaars is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Adriane D.M. Vorselaars has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 22 papers in Physiology and 10 papers in Rheumatology. Recurrent topics in Adriane D.M. Vorselaars's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Sarcoidosis and Beryllium Toxicity Research (22 papers) and Drug-Induced Adverse Reactions (9 papers). Adriane D.M. Vorselaars is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Sarcoidosis and Beryllium Toxicity Research (22 papers) and Drug-Induced Adverse Reactions (9 papers). Adriane D.M. Vorselaars collaborates with scholars based in Netherlands, United States and Germany. Adriane D.M. Vorselaars's co-authors include Jan C. Grutters, Coline H.M. van Moorsel, Marcel Veltkamp, Vera H.M. Deneer, A.M.E. Claessen, Ger T. Rijkers, Ruth G.M. Keijsers, Heleen A. Crommelin, Pieter Zanen and Montse Janssen Bonás and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and CHEST Journal.

In The Last Decade

Adriane D.M. Vorselaars

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriane D.M. Vorselaars Netherlands 16 803 740 190 176 133 35 1.0k
Nabeel Hamzeh United States 20 872 1.1× 864 1.2× 122 0.6× 164 0.9× 186 1.4× 42 1.3k
Andrew G. Nicholson United Kingdom 12 1.1k 1.3× 1.1k 1.4× 106 0.6× 244 1.4× 269 2.0× 21 1.7k
Juan Mañá Spain 18 941 1.2× 711 1.0× 149 0.8× 322 1.8× 161 1.2× 34 1.1k
O P Sharma India 10 1.0k 1.3× 920 1.2× 132 0.7× 208 1.2× 159 1.2× 23 1.4k
Matthew H. Willett United States 5 309 0.4× 388 0.5× 53 0.3× 137 0.8× 147 1.1× 5 792
Kathleen M. Buchheit United States 20 902 1.1× 378 0.5× 296 1.6× 49 0.3× 109 0.8× 66 1.6k
R Mikami France 3 536 0.7× 360 0.5× 56 0.3× 96 0.5× 90 0.7× 6 636
Takuma Yokoyama Japan 15 350 0.4× 195 0.3× 14 0.1× 115 0.7× 190 1.4× 53 793
G. K. Scadding United Kingdom 16 889 1.1× 264 0.4× 59 0.3× 24 0.1× 37 0.3× 24 1.3k
Jean‐Marc Fellrath Switzerland 10 247 0.3× 259 0.3× 28 0.1× 35 0.2× 67 0.5× 26 517

Countries citing papers authored by Adriane D.M. Vorselaars

Since Specialization
Citations

This map shows the geographic impact of Adriane D.M. Vorselaars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriane D.M. Vorselaars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriane D.M. Vorselaars more than expected).

Fields of papers citing papers by Adriane D.M. Vorselaars

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriane D.M. Vorselaars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriane D.M. Vorselaars. The network helps show where Adriane D.M. Vorselaars may publish in the future.

Co-authorship network of co-authors of Adriane D.M. Vorselaars

This figure shows the co-authorship network connecting the top 25 collaborators of Adriane D.M. Vorselaars. A scholar is included among the top collaborators of Adriane D.M. Vorselaars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriane D.M. Vorselaars. Adriane D.M. Vorselaars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harlianto, Netanja I., Pim A. de Jong, Wouter Foppen, et al.. (2025). Aortic, musculoskeletal and organ characteristics on computed tomography in knee osteoarthritis – an explorative study in the IMI-APPROACH cohort. Rheumatology International. 45(3). 62–62.
2.
Bonella, Francesco, Adriane D.M. Vorselaars, & Benjamin Wilde. (2024). Kidney manifestations of sarcoidosis. Journal of Autoimmunity. 149. 103207–103207. 8 indexed citations
3.
Moorsel, Coline H.M. van, et al.. (2023). Improved Survival of IPF patients Treated With Antifibrotic Drugs Compared With Untreated Patients. Lung. 201(4). 335–343. 10 indexed citations
4.
Platteel, Anouk C. M., Adriane D.M. Vorselaars, Montse Janssen Bonás, et al.. (2022). Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases. PLoS ONE. 17(11). e0277007–e0277007. 4 indexed citations
5.
Vorselaars, Adriane D.M., et al.. (2021). Severe pulmonary toxicity associated with inhalation of pyrethroid-based domestic insecticides (Bop/Sapolio): a case series and literature review. Current Opinion in Pulmonary Medicine. 27(4). 271–277. 13 indexed citations
6.
Vorselaars, Adriane D.M., et al.. (2020). Serum Biomarker Ca 15-3 As Predictor of Response to Antifibrotic Treatment and Survival in Idiopathic Pulmonary Fibrosis. Biomarkers in Medicine. 14(11). 997–1007. 8 indexed citations
7.
Bonás, Montse Janssen, et al.. (2020). Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects. Frontiers in Immunology. 11. 1443–1443. 111 indexed citations
8.
Vorselaars, Adriane D.M., et al.. (2020). Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity Pneumonitis. Lung. 198(2). 385–393. 9 indexed citations
9.
Vorselaars, Adriane D.M., et al.. (2019). Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis. EJNMMI Research. 9(1). 54–54. 21 indexed citations
10.
Vorselaars, Adriane D.M., Frouke T. van Beek, Heleen A. Crommelin, et al.. (2018). Efficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosis. Respiratory Medicine. 138. S7–S13. 47 indexed citations
11.
Crommelin, Heleen A., Adriane D.M. Vorselaars, Marjolein Drent, et al.. (2016). Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. Respiratory Medicine. 115. 72–77. 61 indexed citations
12.
Crommelin, Heleen A., Adriane D.M. Vorselaars, Marjolein Drent, et al.. (2016). Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. PA820–PA820. 1 indexed citations
13.
Vorselaars, Adriane D.M., Heleen A. Crommelin, Vera H.M. Deneer, et al.. (2015). Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. European Respiratory Journal. 46(1). 175–185. 106 indexed citations
14.
Vorselaars, Adriane D.M., Coline H.M. van Moorsel, Pieter Zanen, et al.. (2014). ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respiratory Medicine. 109(2). 279–285. 82 indexed citations
15.
Vorselaars, Adriane D.M., Johanna P. Cremers, Jan C. Grutters, & Marjolein Drent. (2014). Cytotoxic agents in sarcoidosis. Current Opinion in Pulmonary Medicine. 20(5). 479–487. 35 indexed citations
16.
Hijdra, Daniëlle, Adriane D.M. Vorselaars, Jan C. Grutters, A.M.E. Claessen, & Ger T. Rijkers. (2013). Phenotypic Characterization of Human Intermediate Monocytes. Frontiers in Immunology. 4. 339–339. 51 indexed citations
17.
Vorselaars, Adriane D.M., et al.. (2013). Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis. Brain Behavior and Immunity. 33. 57–64. 16 indexed citations
18.
Vorselaars, Adriane D.M., et al.. (2013). Changes in disease activity, lung function and quality of life in patients with refractory sarcoidosis after anti-TNF treatment. Expert Opinion on Orphan Drugs. 1(6). 437–443. 11 indexed citations
19.
Hijdra, Daniëlle, Adriane D.M. Vorselaars, Jan C. Grutters, A.M.E. Claessen, & Ger T. Rijkers. (2012). Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes. Journal of Inflammation. 9(1). 38–38. 39 indexed citations
20.
Hasselt, Peter M. van, Adriane D.M. Vorselaars, Ed Nieuwenhuys, et al.. (2009). Vitamin K deficiency bleeding in cholestatic infants with alpha-1-antitrypsin deficiency. Archives of Disease in Childhood Fetal & Neonatal. 94(6). F456–F460. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nabeel Hamzeh Breakdown of academic impact, for papers by Andrew G. Nicholson Breakdown of academic impact, for papers by Juan Mañá Breakdown of academic impact, for papers by O P Sharma Breakdown of academic impact, for papers by Matthew H. Willett Breakdown of academic impact, for papers by Kathleen M. Buchheit Breakdown of academic impact, for papers by R Mikami Breakdown of academic impact, for papers by Takuma Yokoyama Breakdown of academic impact, for papers by G. K. Scadding Breakdown of academic impact, for papers by Jean‐Marc Fellrath
Rankless by CCL
2026